Annual report pursuant to Section 13 and 15(d)
(WorldNews Norway)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from _________________ to _________________ Commission File Number: 001-33216 SONOMA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 68-0423298 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 645 Molly Lane, Suite 150 Woodstock, Georgia 30189 (Address of...